搜索临床试验以:P2B001 每天一次(普拉克索 0.3 毫克/雷沙吉兰 0.75 毫克),
总计553个结果
-
University of California, Davis完全的
-
King's College Hospital NHS TrustKing's College London主动,不招人
-
Helsinn Healthcare SA主动,不招人
-
Fundación Universitaria de Ciencias de la SaludHospital de San Jose终止
-
Tufts Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)完全的
-
Centre hospitalier de l'Université de Montréal...Quebec Researchnetwork on aging招聘中
-
University of MichiganAmerican Academy of Sleep Medicine完全的
-
Wake Forest University Health Sciences主动,不招人
-
Rare Partners srl Impresa SocialeUniversità degli Studi di Ferrara完全的
-
Università degli Studi di FerraraAzienda Ospedaliero, Universitaria Pisana; Rare Partners srl Impresa Sociale; Azienda Ospedaliero...招聘中
-
University of ManitobaHealth Sciences Centre Foundation, Manitoba; Canadian Paraplegic Association; The Manitoba Spinal...完全的
-
The George InstituteNational Health and Medical Research Council, Australia完全的
-
University of North Carolina, Chapel Hill完全的
-
Boston Children's HospitalBeth Israel Deaconess Medical Center; Brigham and Women's Hospital; Thomas Jefferson University招聘中
-
University Medicine GreifswaldWuerzburg University Hospital; University of Göttingen招聘中
-
Washington University School of MedicineHarvard Medical School (HMS and HSDM); University of Manitoba; University Health Network, Toronto 和其他合作者完全的
-
Novartis Pharmaceuticals完全的继发于病理性近视 (PM) 的脉络膜新生血管 (CNV) 导致的视力障碍中国, 印度, 泰国, 香港, 大韩民国, 菲律宾
-
Novartis完全的多发性硬化症美国, 大韩民国, 葡萄牙, 加拿大, 匈牙利, 西班牙, 德国, 英国, 澳大利亚, 阿根廷, 奥地利, 比利时, 巴西, 埃及, 法国, 希腊, 意大利, 瑞士